For patients living with unmet medical needs, the development of effective therapies is critical. To ensure solutions deliver the most meaningful benefits possible, it is the responsibility of sponsors and contract research organisations to develop a complete understanding of any given condition and the literature, as well as seek an array of expert opinions. And yet, even this comprehensive approach does not provide the full picture without involvement from the ultimate end users – the patients themselves.
Patients are the experts on their disease. They understand treatment hurdles and can express which outcomes are most meaningful to them, which may not always align with those deemed to be of greatest importance by clinicians and industry. Only by including patient insights across the entire process can we efficiently mitigate risk while navigating the incredibly complex environment of drug development.
But what benefits will sponsors see by including patient perspectives in their decision-making? From informing asset planning and endpoint selection to medical communications and market access strategies, the advantages of these insights are endless.
Read the article in full here.
